Top 10 Companies in the United States Biomaterials Market (2026): Market Leaders Driving Innovation

MARKET INSIGHTS

Global Biomaterials market size was valued at USD 23.45 billion in 2024. The market is projected to grow from USD 25.1 billion in 2025 to USD 42.8 billion by 2032, exhibiting a CAGR of 7.8% during the forecast period.

Biomaterials are engineered substances designed to interact with biological systems for medical applications, including implants, tissue engineering scaffolds, drug delivery systems, and diagnostic devices. These materials range from metals and ceramics to polymers and composites, each selected for specific biocompatibility and functional properties.

The market growth is driven by increasing demand for orthopedic and dental implants, where biomaterials accounted for 38% of total applications in 2024. Advances in regenerative medicine are accelerating adoption, with 3D-printed biomaterial solutions growing at 22% annually. The rising prevalence of chronic diseases requiring medical implants – projected to affect 45% of the US population by 2030 – further fuels market expansion. Key players like Zimmer Biomet and Stryker Corporation are investing heavily in smart biomaterials with sensor capabilities, evidenced by a 60% increase in related patents filed since 2022.

United States Biomaterials Market – View in Detailed Research Report

🔟 1. Zimmer Biomet

Headquarters: Warsaw, Indiana, USA
Key Offering: Orthopedic implants, joint replacement systems, spinal devices

Zimmer Biomet has positioned itself as a leader in orthopedic biomaterials, delivering high‑performance alloys and composite materials that enhance osseointegration and reduce revision rates. Their portfolio includes titanium‑based implants with advanced surface treatments and polymeric spacers for joint reconstruction.

Sustainability & Growth Initiatives: The company is integrating biodegradable polymeric coatings to reduce implant retrieval surgeries and investing in 3D‑printed patient‑specific implants to lower material waste.

• Launch of a titanium‑silicon alloy with 30% higher fatigue life.
• Partnership with a university research lab for smart sensor integration.
• Commitment to reduce carbon footprint of manufacturing by 15% by 2030.

Download FREE Sample Report

9️⃣ 2. DePuy Synthes (Johnson & Johnson)

Headquarters: Raynham, Massachusetts, USA
Key Offering: Metal and ceramic orthopedic implants, trauma fixation devices

DePuy Synthes focuses on high‑strength metallic alloys and bioactive ceramics that promote bone growth, offering a comprehensive range of hip, knee, and spinal solutions. Their research emphasizes additive manufacturing for complex geometries and personalized implants.

Sustainability & Growth Initiatives: The firm is scaling up its nanostructured ceramic coatings to improve wear resistance and has launched a circular economy program for used implant components.

• New bioactive ceramic hip components with 25% higher surface roughness.
• Collaboration with a global materials consortium to standardize nanocoatings.
• Reduction of waste by 20% through reusable tooling.

Download FREE Sample Report

8️⃣ 3. Medtronic

Headquarters: Minneapolis, Minnesota, USA
Key Offering: Cardiovascular stents, drug‑eluting devices, neural interfaces

Medtronic’s biomaterial portfolio centers on advanced polymeric stents and neural interface coatings that enhance biocompatibility. Their research drives the integration of drug delivery systems with structural supports for vascular and neural applications.

Sustainability & Growth Initiatives: The company is developing biodegradable polymeric stents to reduce long‑term foreign body presence and partnering with biotech firms for smart drug‑delivery platforms.

• Launch of a drug‑eluting polymeric stent with 40% faster drug release.
• Strategic alliance with a nanotech startup for neural interface coatings.
• Investment of USD 200 million in R&D for next‑generation biomaterials.

Download FREE Sample Report

7️⃣ 4. Stryker Corporation

Headquarters: Kalamazoo, Michigan, USA
Key Offering: Orthopedic implants, trauma fixation, spinal devices

Stryker is a pioneer in smart biomaterials, embedding sensors into implants to monitor load, wear, and biological integration. Their portfolio includes titanium alloys with integrated micro‑sensors for real‑time performance data.

Sustainability & Growth Initiatives: The company is reducing material usage by 10% through design optimization and has invested in a closed‑loop recycling program for titanium scrap.

• New sensor‑enabled knee replacement with 24/7 data telemetry.
• Collaboration with a university for smart biomaterial research.
• Goal to cut CO2 emissions by 12% by 2035.

Download FREE Sample Report

6️⃣ 5. Invibio (Victrex plc)

Headquarters: Derry, Northern Ireland, United Kingdom
Key Offering: High‑performance polymeric biomaterials, bioactive ceramics

Invibio specializes in advanced polymer composites and bioactive ceramic coatings that enhance implant integration and reduce infection rates. Their research focuses on nanostructured surfaces for improved osseointegration.

Sustainability & Growth Initiatives: The company is developing low‑toxicity polymer blends and has partnered with a European consortium to standardize ceramic surface treatments.

• Launch of a low‑toxicity polymer for spinal implants.
• Partnership with a European research center for ceramic coatings.
• Investment of USD 150 million in sustainable material R&D.

Download FREE Sample Report

5️⃣ 6. RTI Surgical

Headquarters: San Diego, California, USA
Key Offering: Biodegradable polymeric implants, orthopedic fixation devices

RTI Surgical focuses on biodegradable polymeric solutions that eliminate the need for secondary surgeries. Their products include resorbable screws and plates designed for orthopedic applications.

Sustainability & Growth Initiatives: The firm is expanding its portfolio of biodegradable polymers and collaborating with academic institutions to refine degradation kinetics.

• New resorbable plate with 30% faster degradation.
• Collaboration with a university to study in‑vivo degradation.
• Goal to reduce plastic waste by 25% by 2030.

Download FREE Sample Report

4️⃣ 7. Wright Medical Group (Stryker)

Headquarters: Minneapolis, Minnesota, USA
Key Offering: Advanced orthopedic biomaterials, joint replacement systems

Wright Medical Group develops high‑performance polymeric and metallic biomaterials for joint replacement and trauma fixation. Their research emphasizes patient‑specific designs and smart sensor integration.

Sustainability & Growth Initiatives: The company is investing in 3D‑printed joint components and partnering with material science labs to reduce material waste.

• New 3D‑printed hip component with 20% weight reduction.
• Collaboration with a material science lab for smart biomaterial research.
• Target to cut manufacturing waste by 18% by 2035.

Download FREE Sample Report

3️⃣ 8. Allergan (AbbVie Inc.)

Headquarters: Irvine, California, USA
Key Offering: Biologic products, drug delivery systems, biomaterial‑based therapeutics

Allergan focuses on biologic therapies delivered via polymeric carriers and biomaterial scaffolds. Their research targets improved drug release profiles and reduced immunogenicity.

Sustainability & Growth Initiatives: The firm is developing biodegradable polymeric carriers for biologics and collaborating with universities on smart drug delivery.

• Launch of a biodegradable polymeric carrier for biologic drugs.
• Partnership with a university for smart delivery systems.
• Investment of USD 120 million in biomaterial R&D.

Download FREE Sample Report

2️⃣ 9. GELITA AG

Headquarters: Wetzlar, Germany
Key Offering: Collagen‑based biomaterials, wound healing products, tissue engineering scaffolds

GELITA AG specializes in collagen and gelatin biomaterials for wound care and tissue engineering. Their products include collagen‑based dressings and scaffolds that promote cell adhesion and tissue regeneration.

Sustainability & Growth Initiatives: The company is exploring plant‑derived collagen alternatives and has partnered with biotech firms for sustainable sourcing.

• New plant‑derived collagen dressing with 30% higher cell adhesion.
• Collaboration with a biotech firm for sustainable collagen sourcing.
• Goal to reduce environmental impact of production by 20% by 2030.

Download FREE Sample Report

1️⃣ 10. Collagen Matrix Inc.

Headquarters: New York, New York, USA
Key Offering: Collagen matrices, tissue engineering scaffolds, regenerative medicine products

Collagen Matrix Inc. develops collagen matrices that support cell growth and tissue regeneration. Their portfolio includes matrices for bone, cartilage, and soft tissue applications.

Sustainability & Growth Initiatives: The firm is integrating bio‑fabricated collagen and partnering with academic labs to optimize matrix properties.

• New bio‑fabricated collagen matrix with 25% higher mechanical strength.
• Collaboration with a university for matrix optimization.
• Investment of USD 100 million in regenerative biomaterials.

Download FREE Sample Report

---

Outlook

The United States biomaterials market is projected to grow from USD 25.1 billion in 2025 to USD 42.8 billion by 2032, driven by continued advancements in regenerative medicine, increasing prevalence of chronic diseases, and the adoption of minimally invasive surgical procedures. The market is expected to maintain a CAGR of 7.8% through the forecast period.

Future Trends

• Smart biomaterials with integrated biosensors for real‑time monitoring.
• 3D‑printed, patient‑specific implants leveraging additive manufacturing.
• Nanostructured surface coatings to improve osseointegration and reduce infection.
• Biodegradable polymeric implants to eliminate revision surgeries.
• Enhanced drug‑delivery platforms using polymeric carriers.

Get Full Report